Metabolic Dysfunction-Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population-Based Study.

ABSTRACT:

Background

The recent reclassification of steatotic liver disease into metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated alcohol-related liver disease has highlighted their potential cardiovascular implications. This study aimed to investigate the impact of MASLD and metabolic dysfunction-associated alcohol-related liver disease on the risk of newly diagnosed atrial fibrillation (AF).

Methods

Data from 362 285 participants who underwent a health screening in 2009 to 2010, sourced from the Korean National Health Insurance database, were identified, and we retrospectively analyzed their data through 2019. Excluding those with other liver diseases and heavy alcoholics, 206 455 participants with a fatty liver index were include

SUBMITTER: Kim M 

PROVIDER: S-EPMC12533673 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature